Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Peptide + ciclosporin combination improves renal allograft survival and function

Nov. 14, 1997

No Comments

Anti-CD45 MAb prolongs islet xenograft survival in diabetic mice

Nov. 14, 1997

No Comments

BioChem Pharma moves cell culture-based influenza vaccine to phase II/III

Nov. 12, 1997

No Comments

LXR to commence pivotal trials with HK-Cardiosol

Nov. 10, 1997

No Comments

Mechanism of action of triptolide investigated in human T-cells

Nov. 10, 1997

No Comments

Confirmatory trials of Alpha-Beta's Betafectin to begin

Nov. 10, 1997

No Comments

Merck to develop Vical technology for therapeutic vaccines

Nov. 7, 1997

No Comments

Heat shock proteins: a new vaccine strategy

Nov. 6, 1997

No Comments

New human rabies vaccine cleared in U.S.

Nov. 4, 1997

No Comments

Novel class of compound enhances IFN-gamma and NT-3 activity

Nov. 4, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Immune
RSS

Peptide + ciclosporin combination improves renal allograft survival and function

Anti-CD45 MAb prolongs islet xenograft survival in diabetic mice

BioChem Pharma moves cell culture-based influenza vaccine to phase II/III

LXR to commence pivotal trials with HK-Cardiosol

Mechanism of action of triptolide investigated in human T-cells

Confirmatory trials of Alpha-Beta's Betafectin to begin

Merck to develop Vical technology for therapeutic vaccines

Heat shock proteins: a new vaccine strategy

New human rabies vaccine cleared in U.S.

Novel class of compound enhances IFN-gamma and NT-3 activity

Today's news in brief

Today's news in brief

Second insulin receptor offers new therapeutic avenues

KITE-753, a rapid manufactured CAR T therapy with superior antitumor efficacy and enhanced expansion in vivo

Boryung invests $10M in Intuitive Machines for outer space R&D

Immune RSS

Immune
RSS